Publications by authors named "Laura Doni"

Claim this Profile
A
Adjuvant immunotherapy in high-risk renal cell carcinoma: Indications, limitations, and perspectives. A consensus statement from the GIOTTO uro-oncology group.
Giandomenico Roviello, Federico Paolieri, Martina Catalano, Luca Galli, Laura Doni

Crit Rev Oncol Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overlapping Extremes: An Analysis of Avelumab Maintenance and Pembrolizumab in Advanced Urothelial Carcinoma.
Martina Catalano, Irene de Gennaro Aquino, Ismaela Anna Vascotto, Adriana Guarino, Silvia Mancini, Laura Doni

Oncol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of Avelumab maintenance in advanced urothelial carcinoma: results from the Italian multicenter MALVA study (Meet-URO 25).
Giandomenico Roviello, Elisabetta Gambale, Irene De Gennaro Aquino, Marco Maruzzo, Carlo Messina, Laura Doni

Oncologist· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and impact of immune combination therapies adverse events in advanced renal cell carcinoma patients.
Martina Catalano, Giulia Venturi, Alessia Salfi, Francesco Bloise, Federico Paolieri, Laura Doni

Immunotherapy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-Inducible Factor in Renal Cell Carcinoma: From Molecular Insights to Targeted Therapies.
Giandomenico Roviello, Irene De Gennaro, Ismaela Vascotto, Giulia Venturi, Alberto D'Angelo, Laura Doni

Genes (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head and neck melanoma: the eyelid region has a better prognosis and easier management. A retrospective survey and systematic review.
Federica Dini, Pietro Susini, Biancamaria Zuccaro, Giuseppe Nisi, Roberto Cuomo, Laura Doni

Melanoma Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer.
Marzia Del Re, Stefania Crucitta, Nicole Brighi, Stefania Kinspergher, Chiara Mercinelli, Laura Doni

Clin Genitourin Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Use of Cemiplimab in a Very Elderly Patient With Cutaneous Squamous Cell Carcinoma.
Elisabetta Gambale, Giulia Venturi, Adriana Guarino, Ismaela Anna Vascotto, Serena Pillozzi, Laura Doni

Cancer Diagn Progn· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Front-Line Therapeutic Strategy in Metastatic Hormone Sensitive Prostate Cancer: An Updated Therapeutic Algorithm.
Federico Paolieri, Enrico Sammarco, Marco Ferrari, Alessia Salfi, Adele Bonato, Laura Doni

Clin Genitourin Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25).
Elisabetta Gambale, Marco Maruzzo, Carlo Messina, Irene De Gennaro Aquino, Ismaela Anna Vascotto, Laura Doni

Clin Genitourin Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Periocular sebaceous carcinoma: updates in the diagnosis, treatment, staging, and management.
Federica Dini, Pietro Susini, Giuseppe Nisi, Roberto Cuomo, Luca Grimaldi, Laura Doni

Int J Dermatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Treatments and Management of Metastatic Renal Cell Carcinoma Patients: An Italian Interdisciplinary Uro-Oncologic Group Algorithm.
Francesco Bloise, Fiorella Manfredi, Luca Zatteri, Giovanni Dima, Chiara Carli, Laura Doni

Cells· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or Pazopanib.
Martina Catalano, Ugo De Giorgi, Davide Bimbatti, Sebastiano Buti, Giuseppe Procopio, Laura Doni

Clin Genitourin Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermoscopy as a Tool for Identifying Potentially Metastatic Thin Melanoma: A Clinical-Dermoscopic and Histopathological Case-Control Study.
Vincenzo De Giorgi, Flavia Silvestri, Giovanni Cecchi, Federico Venturi, Biancamaria Zuccaro, Laura Doni

Cancers (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03).
Giuseppe Procopio, Mélanie Claps, Chiara Pircher, Luca Porcu, Pierangela Sepe, Laura Doni

Tumori· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma.
Martina Catalano, Ugo De Giorgi, Marco Maruzzo, Davide Bimbatti, Sebastiano Buti, Laura Doni

Biomedicines· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND study.
Giandomenico Roviello, Elisabetta Gambale, Roberta Giorgione, Daniele Santini, Marco Stellato, Laura Doni

Cancer Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous immune-related adverse events and photodamaged skin in patients with metastatic melanoma: could nicotinamide be useful?
Vincenzo De Giorgi, Jacopo Colombo, Luciana Trane, Flavia Silvestri, Federico Venturi, Laura Doni

Clin Exp Dermatol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors.
Giandomenico Roviello, Martina Catalano, Ugo De Giorgi, Marco Maruzzo, Sebastiano Buti, Laura Doni

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence of Dysgeusia in Patients Being Treated for Cancer.
Jaclyn Di Meglio, Monica Dinu, Laura Doni, Gemma Rossi, Roberta Giorgione

Nutr Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy.
Lucrezia Becattini, Calogero Saieva, Laura Doni, Giandomenico Roviello, Pietro Spatafora

Medicina (Kaunas)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment.
Elisabetta Gambale, Sara Fancelli, Enrico Caliman, Maria Cristina Petrella, Laura Doni

J Immunother Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?
Ernesto Rossi, Melissa Bersanelli, Alain Jonathan Gelibter, Nicolò Borsellino, Claudia Caserta, Laura Doni

Curr Oncol Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of periocular advanced basal cell carcinoma with Hedgehog pathway inhibitors: A single-center study and a new dedicated therapeutic protocol.
Vincenzo De Giorgi, Luciana Trane, Giulia Pieretti, Nicola Santoro, Flavia Silvestri, Laura Doni

Dermatol Reports· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study.
Agnese Paderi, Sara Fancelli, Enrico Caliman, Serena Pillozzi, Elisabetta Gambale, Laura Doni

Curr Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis